circUBAP2 exacerbates malignant capabilities of NSCLC by targeting KLF4 through miR-3182 modulation (vol 13, pg 11083, 2021)Guanying Zheng,Jianyuan Huang,Wenshu Chen,Peilin You,Yun Ding,Pengjie TuAGING-US（2022）引用 0|浏览4暂无评分关键词chemo-resistance, NSCLC, circUBAP2, therapeutic targetAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
